GENFIT
Develops therapies and diagnostics for patients with rare and severe liver diseases.
GNFT | PA
Overview
Corporate Details
- ISIN(s):
- FR0004163111 (+2 more)
- LEI:
- 969500XPWN2DMZQA5X73
- Country:
- France
- Address:
- 885 AVENUE EUGENE AVINEE, 59120 LOOS
- Website:
- https://www.genfit.com
Description
GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-19 07:30 |
GENFIT : acquisition de Versantis AG, société biopharmaceutique de phase cliniq…
|
French | 184.9 KB | ||
| 2022-09-19 07:30 |
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding…
|
English | 180.9 KB | ||
| 2022-09-13 22:10 |
La FDA accorde la désignation d’Orphan Drug à GNS561 pour le traitement du chol…
|
French | 144.1 KB | ||
| 2022-09-13 22:10 |
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholang…
|
English | 192.5 KB | ||
| 2022-07-08 22:10 |
GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Indu…
|
French | 292.3 KB | ||
| 2022-07-08 22:10 |
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commer…
|
English | 271.7 KB | ||
| 2022-05-25 22:10 |
GENFIT : Résultats de l’Assemblée Générale Mixte du 25 mai 2022
|
French | 159.4 KB | ||
| 2022-05-25 22:10 |
GENFIT: May 25, 2022 Combined Shareholders Meeting results
|
English | 156.3 KB | ||
| 2022-05-11 22:10 |
GENFIT : Information financière du premier trimestre 2022 (Données non auditées…
|
French | 151.1 KB | ||
| 2022-05-11 22:10 |
GENFIT Reports First Quarter 2022 Financial Information (Unaudited financial in…
|
English | 155.0 KB | ||
| 2022-04-29 22:10 |
GENFIT : Mise à disposition du Document d’Enregistrement Universel 2021, du Rap…
|
French | 144.8 KB | ||
| 2022-04-29 22:10 |
GENFIT Announces Publication of the 2021 Universal Registration Document; the 2…
|
English | 150.0 KB | ||
| 2022-04-29 16:19 |
Document d'Enregistrement Universel 2021
|
French | 6.3 MB | ||
| 2022-04-29 16:19 |
Document d'Enregistrement Universel 2021
|
French | 6.3 MB | ||
| 2022-04-20 22:10 |
GENFIT : Assemblée Générale Mixte du 25 mai 2022 — modalités de mise à disposit…
|
French | 136.3 KB |
Automate Your Workflow. Get a real-time feed of all GENFIT filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GENFIT
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GENFIT via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-07-07 | N/A | Other | Buy | 5,300 | 19,488.10 EUR |
| 2023-07-06 | N/A | Other | Buy | 1,100 | 4,048.00 EUR |
| 2023-07-05 | N/A | Other | Buy | 10,000 | 37,061.00 EUR |
| 2023-07-03 | N/A | Other | Buy | 5,300 | 18,769.95 EUR |
Peer Companies
